91 related articles for article (PubMed ID: 11912171)
1. Fibroblast growth factor receptor 1 phosphotyrosine 766: molecular target for prevention of progression of prostate tumors to malignancy.
Wang F; McKeehan K; Yu C; McKeehan WL
Cancer Res; 2002 Mar; 62(6):1898-903. PubMed ID: 11912171
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells.
Feng S; Wang F; Matsubara A; Kan M; McKeehan WL
Cancer Res; 1997 Dec; 57(23):5369-78. PubMed ID: 9393762
[TBL] [Abstract][Full Text] [Related]
3. Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors.
Wu X; Jin C; Wang F; Yu C; McKeehan WL
Cancer Res; 2003 Aug; 63(16):4936-44. PubMed ID: 12941818
[TBL] [Abstract][Full Text] [Related]
4. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors.
Jin C; Wang F; Wu X; Yu C; Luo Y; McKeehan WL
Cancer Res; 2004 Jul; 64(13):4555-62. PubMed ID: 15231666
[TBL] [Abstract][Full Text] [Related]
5. Chronic activity of ectopic type 1 fibroblast growth factor receptor tyrosine kinase in prostate epithelium results in hyperplasia accompanied by intraepithelial neoplasia.
Wang F; McKeehan K; Yu C; Ittmann M; McKeehan WL
Prostate; 2004 Jan; 58(1):1-12. PubMed ID: 14673947
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2.
Matsubara A; Kan M; Feng S; McKeehan WL
Cancer Res; 1998 Apr; 58(7):1509-14. PubMed ID: 9537256
[TBL] [Abstract][Full Text] [Related]
7. Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation.
Freeman KW; Gangula RD; Welm BE; Ozen M; Foster BA; Rosen JM; Ittmann M; Greenberg NM; Spencer DM
Cancer Res; 2003 Oct; 63(19):6237-43. PubMed ID: 14559809
[TBL] [Abstract][Full Text] [Related]
8. A rare premalignant prostate tumor epithelial cell syndecan-1 forms a fibroblast growth factor-binding complex with progression-promoting ectopic fibroblast growth factor receptor 1.
Wu X; Kan M; Wang F; Jin C; Yu C; McKeehan WL
Cancer Res; 2001 Jul; 61(13):5295-302. PubMed ID: 11431373
[TBL] [Abstract][Full Text] [Related]
9. The intracellular microenvironment in host cell-specific phosphorylation of SNT1 by the FGFR1 tyrosine kinase.
Jin CL; McKeehan K; Lambert D; Wang F
Shi Yan Sheng Wu Xue Bao; 2002 Sep; 35(3):184-90. PubMed ID: 15344379
[TBL] [Abstract][Full Text] [Related]
10. Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice.
Freeman KW; Welm BE; Gangula RD; Rosen JM; Ittmann M; Greenberg NM; Spencer DM
Cancer Res; 2003 Dec; 63(23):8256-63. PubMed ID: 14678983
[TBL] [Abstract][Full Text] [Related]
11. Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate.
Jin C; McKeehan K; Guo W; Jauma S; Ittmann MM; Foster B; Greenberg NM; McKeehan WL; Wang F
Cancer Res; 2003 Dec; 63(24):8784-90. PubMed ID: 14695195
[TBL] [Abstract][Full Text] [Related]
12. Restoration of fibroblast growth factor receptor2 suppresses growth and tumorigenicity of malignant human prostate carcinoma PC-3 cells.
Yasumoto H; Matsubara A; Mutaguchi K; Usui T; McKeehan WL
Prostate; 2004 Nov; 61(3):236-42. PubMed ID: 15368475
[TBL] [Abstract][Full Text] [Related]
13. Ligand-independent activation of tyrosine kinase in fibroblast growth factor receptor 1 by fusion with beta-galactosidase.
Kouhara H; Kurebayashi S; Hashimoto K; Kasayama S; Koga M; Kishimoto T; Sato B
Oncogene; 1995 Jun; 10(12):2315-22. PubMed ID: 7784079
[TBL] [Abstract][Full Text] [Related]
14. Integrative nuclear FGFR1 signaling (INFS) as a part of a universal "feed-forward-and-gate" signaling module that controls cell growth and differentiation.
Stachowiak MK; Fang X; Myers JM; Dunham SM; Berezney R; Maher PA; Stachowiak EK
J Cell Biochem; 2003 Nov; 90(4):662-91. PubMed ID: 14587025
[TBL] [Abstract][Full Text] [Related]
15. The role of fibroblast growth factors and their receptors in prostate cancer.
Kwabi-Addo B; Ozen M; Ittmann M
Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
17. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
Lee YF; Lin WJ; Huang J; Messing EM; Chan FL; Wilding G; Chang C
Cancer Res; 2002 Nov; 62(21):6039-44. PubMed ID: 12414626
[TBL] [Abstract][Full Text] [Related]
18. Cellular signaling by fibroblast growth factor receptors.
Eswarakumar VP; Lax I; Schlessinger J
Cytokine Growth Factor Rev; 2005 Apr; 16(2):139-49. PubMed ID: 15863030
[TBL] [Abstract][Full Text] [Related]
19. bFGF signaling and v-Myb cooperate in sustained growth of primitive erythroid progenitors.
Bartůnek P; Pajer P; Karafiát V; Blendinger G; Dvorák M; Zenke M
Oncogene; 2002 Jan; 21(3):400-10. PubMed ID: 11821952
[TBL] [Abstract][Full Text] [Related]
20. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]